Please enable JavaScript to continue using this application.

Compare $IBRX vs $TWST | Chartloom

Compare

$IBRX vs $TWST

Immunitybio Inc · Twist Bioscience Corp

IBRX

Immunitybio Inc

TWST

Twist Bioscience Corp

Compare $IBRX vs $TWST

Comparing Immunitybio Inc and Twist Bioscience Corp

IBRXImmunitybio Inc

TWSTTwist Bioscience Corp

IBRXImmunitybio Inc

Market cap

$11.01B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

40.40x

Rev growth (TTM)

192.9%

YTD performance

420.3%

52W performance

315.4%

FCF yield

-2.6%

TWSTTwist Bioscience Corp

Market cap

$9.95B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

18.83x

Rev growth (TTM)

19.2%

YTD performance

393.3%

52W performance

387.3%

FCF yield

-1.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IBRX

TWST

Detailed metrics comparison

IBRX

Immunitybio Inc

TWST

Twist Bioscience Corp

Market Cap

IBRX$11.01B

TWST$9.95B

Enterprise Value

IBRX$12.12B

TWST$9.83B

Price

IBRX$10.51

TWST$159.78

P/E Ratio

IBRXN/A

TWSTN/A

P/S Ratio

IBRX66.39x

TWST23.04x

EV/Sales

IBRX73.11x

TWST22.77x

EV/EBITDA

IBRX0.00x

TWST0.00x

P/B Ratio

IBRX73.35x

TWST27.87x

P/FCF Ratio

IBRXN/A

TWSTN/A

EV/FCF

IBRX-42.01x

TWST-100.10x

PEG Ratio

IBRXN/A

TWSTN/A

Forward P/E (NTM)

IBRXN/A

TWSTN/A

Forward P/S (NTM)

IBRX40.40x

TWST18.83x

Revenue (TTM)

IBRX$166M

TWST$432M

Revenue Growth (YoY)

IBRX192.9%

TWST19.2%

Forward Rev Growth

IBRX111.5%

TWST15.0%

Gross Margin (TTM)

IBRX99.3%

TWST52.0%

Operating Margin (TTM)

IBRX0.0%

TWST0.0%

EBITDA Margin (TTM)

IBRX-141.9%

TWST-26.0%

Net Margin (TTM)

IBRX-598.6%

TWST-31.7%

FCF Margin (TTM)

IBRX-174.0%

TWST-22.7%

Net Income (TTM)

IBRX$-992M

TWST$-137M

FCF (TTM)

IBRX$-289M

TWST$-98M

EPS (TTM)

IBRX-$0.95

TWST-$2.19

ROE (TTM)

IBRX-19329.0%

TWST-2989.0%

ROA (TTM)

IBRX-17288.0%

TWST-2080.0%

ROIC (TTM)

IBRX-19300.0%

TWST-2989.0%

Cash

IBRX$76M

TWST$117M

Debt

IBRX$1.19B

TWST$0

Net Cash/Debt

IBRX$-1.11B

TWST$117M

Current Ratio (TTM)

IBRX5.72x

TWST2.67x

Quick Ratio (TTM)

IBRX5.36x

TWST2.30x

Debt/Equity (TTM)

IBRX0.01x

TWST0.00x

Debt/Assets (TTM)

IBRX0.0%

TWST0.0%

Interest Coverage (TTM)

IBRXN/A

TWSTN/A

Net Debt/EBITDA (TTM)

IBRX0.00x

TWST0.00x

Beta

IBRX0.17

TWST2.17

52W Performance

IBRX315.4%

TWST387.3%

YTD Performance

IBRX420.3%

TWST393.3%

% from 52W High

IBRX-15.4%

TWST-27.3%

% from 52W Low

IBRX439.0%

TWST585.8%

Asset Turnover (TTM)

IBRX0.29x

TWST0.66x

FCF Yield (TTM)

IBRX-2.6%

TWST-1.0%

Earnings Yield (TTM)

IBRX-9.0%

TWST-1.4%

Dividend Yield (TTM)

IBRXN/A

TWSTN/A

Rule of 40

IBRX18.9

TWST-3.6

EV/GP/RG

IBRX1.12

TWST1.94

Ticker research

View IBRX research View TWST research

Metric	IBRX Immunitybio Inc	TWST Twist Bioscience Corp
Market & Valuation
Market Cap	$11.01B	$9.95B
Enterprise Value	$12.12B	$9.83B
Price	$10.51	$159.78
P/E Ratio	N/A	N/A
P/S Ratio	66.39x	23.04x
EV/Sales	73.11x	22.77x
EV/EBITDA	0.00x	0.00x
P/B Ratio	73.35x	27.87x
P/FCF Ratio	N/A	N/A
EV/FCF	-42.01x	-100.10x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	40.40x	18.83x
Revenue & Growth
Revenue (TTM)	$166M	$432M
Revenue Growth (YoY)	192.9%	19.2%
Forward Rev Growth	111.5%	15.0%
Profitability
Gross Margin (TTM)	99.3%	52.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-141.9%	-26.0%
Net Margin (TTM)	-598.6%	-31.7%
FCF Margin (TTM)	-174.0%	-22.7%
Net Income (TTM)	$-992M	$-137M
FCF (TTM)	$-289M	$-98M
EPS (TTM)	-$0.95	-$2.19
ROE (TTM)	-19329.0%	-2989.0%
ROA (TTM)	-17288.0%	-2080.0%
ROIC (TTM)	-19300.0%	-2989.0%
Financial Health
Cash	$76M	$117M
Debt	$1.19B	$0
Net Cash/Debt	$-1.11B	$117M
Current Ratio (TTM)	5.72x	2.67x
Quick Ratio (TTM)	5.36x	2.30x
Debt/Equity (TTM)	0.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.17	2.17
52W Performance	315.4%	387.3%
YTD Performance	420.3%	393.3%
% from 52W High	-15.4%	-27.3%
% from 52W Low	439.0%	585.8%
Efficiency & Yields
Asset Turnover (TTM)	0.29x	0.66x
FCF Yield (TTM)	-2.6%	-1.0%
Earnings Yield (TTM)	-9.0%	-1.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	18.9	-3.6
EV/GP/RG	1.12	1.94
Ticker research	View IBRX research	View TWST research

Valuation

P/S Ratio

TWST

23.04x

IBRX

66.39x

EV/FCF

TWST

-100.10x

IBRX

-42.01x

Growth & revenue

Revenue Growth TTM

IBRX

192.9%

TWST

19.2%

Forward Revenue Growth

IBRX

111.5%

TWST

15.0%

Profitability & performance

Gross Margin

IBRX

99.3%

TWST

52.0%

ROE

TWST

-2989.0%

IBRX

-19329.0%

FCF Yield %

TWST

-1.0%

IBRX

-2.6%

52-Week Performance

TWST

387.3%

IBRX

315.4%

Detailed metrics comparison

IBRX

Immunitybio Inc

TWST

Twist Bioscience Corp

Market Cap

IBRX$11.01B

TWST$9.95B

Enterprise Value

IBRX$12.12B

TWST$9.83B

Price

IBRX$10.51

TWST$159.78

P/E Ratio

IBRXN/A

TWSTN/A

P/S Ratio

IBRX66.39x

TWST23.04x

EV/Sales

IBRX73.11x

TWST22.77x

EV/EBITDA

IBRX0.00x

TWST0.00x

P/B Ratio

IBRX73.35x

TWST27.87x

P/FCF Ratio

IBRXN/A

TWSTN/A

EV/FCF

IBRX-42.01x

TWST-100.10x

PEG Ratio

IBRXN/A

TWSTN/A

Forward P/E (NTM)

IBRXN/A

TWSTN/A

Forward P/S (NTM)

IBRX40.40x

TWST18.83x

Revenue (TTM)

IBRX$166M

TWST$432M

Revenue Growth (YoY)

IBRX192.9%

TWST19.2%

Forward Rev Growth

IBRX111.5%

TWST15.0%

Gross Margin (TTM)

IBRX99.3%

TWST52.0%

Operating Margin (TTM)

IBRX0.0%

TWST0.0%

EBITDA Margin (TTM)

IBRX-141.9%

TWST-26.0%

Net Margin (TTM)

IBRX-598.6%

TWST-31.7%

FCF Margin (TTM)

IBRX-174.0%

TWST-22.7%

Net Income (TTM)

IBRX$-992M

TWST$-137M

FCF (TTM)

IBRX$-289M

TWST$-98M

EPS (TTM)

IBRX-$0.95

TWST-$2.19

ROE (TTM)

IBRX-19329.0%

TWST-2989.0%

ROA (TTM)

IBRX-17288.0%

TWST-2080.0%

ROIC (TTM)

IBRX-19300.0%

TWST-2989.0%

Cash

IBRX$76M

TWST$117M

Debt

IBRX$1.19B

TWST$0

Net Cash/Debt

IBRX$-1.11B

TWST$117M

Current Ratio (TTM)

IBRX5.72x

TWST2.67x

Quick Ratio (TTM)

IBRX5.36x

TWST2.30x

Debt/Equity (TTM)

IBRX0.01x

TWST0.00x

Debt/Assets (TTM)

IBRX0.0%

TWST0.0%

Interest Coverage (TTM)

IBRXN/A

TWSTN/A

Net Debt/EBITDA (TTM)

IBRX0.00x

TWST0.00x

Beta

IBRX0.17

TWST2.17

52W Performance

IBRX315.4%

TWST387.3%

YTD Performance

IBRX420.3%

TWST393.3%

% from 52W High

IBRX-15.4%

TWST-27.3%

% from 52W Low

IBRX439.0%

TWST585.8%

Asset Turnover (TTM)

IBRX0.29x

TWST0.66x

FCF Yield (TTM)

IBRX-2.6%

TWST-1.0%

Earnings Yield (TTM)

IBRX-9.0%

TWST-1.4%

Dividend Yield (TTM)

IBRXN/A

TWSTN/A

Rule of 40

IBRX18.9

TWST-3.6

EV/GP/RG

IBRX1.12

TWST1.94

Ticker research

View IBRX research View TWST research

Metric	IBRX Immunitybio Inc	TWST Twist Bioscience Corp
Market & Valuation
Market Cap	$11.01B	$9.95B
Enterprise Value	$12.12B	$9.83B
Price	$10.51	$159.78
P/E Ratio	N/A	N/A
P/S Ratio	66.39x	23.04x
EV/Sales	73.11x	22.77x
EV/EBITDA	0.00x	0.00x
P/B Ratio	73.35x	27.87x
P/FCF Ratio	N/A	N/A
EV/FCF	-42.01x	-100.10x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	40.40x	18.83x
Revenue & Growth
Revenue (TTM)	$166M	$432M
Revenue Growth (YoY)	192.9%	19.2%
Forward Rev Growth	111.5%	15.0%
Profitability
Gross Margin (TTM)	99.3%	52.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-141.9%	-26.0%
Net Margin (TTM)	-598.6%	-31.7%
FCF Margin (TTM)	-174.0%	-22.7%
Net Income (TTM)	$-992M	$-137M
FCF (TTM)	$-289M	$-98M
EPS (TTM)	-$0.95	-$2.19
ROE (TTM)	-19329.0%	-2989.0%
ROA (TTM)	-17288.0%	-2080.0%
ROIC (TTM)	-19300.0%	-2989.0%
Financial Health
Cash	$76M	$117M
Debt	$1.19B	$0
Net Cash/Debt	$-1.11B	$117M
Current Ratio (TTM)	5.72x	2.67x
Quick Ratio (TTM)	5.36x	2.30x
Debt/Equity (TTM)	0.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.17	2.17
52W Performance	315.4%	387.3%
YTD Performance	420.3%	393.3%
% from 52W High	-15.4%	-27.3%
% from 52W Low	439.0%	585.8%
Efficiency & Yields
Asset Turnover (TTM)	0.29x	0.66x
FCF Yield (TTM)	-2.6%	-1.0%
Earnings Yield (TTM)	-9.0%	-1.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	18.9	-3.6
EV/GP/RG	1.12	1.94
Ticker research	View IBRX research	View TWST research